Arginine-Rich Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Hexapeptide Inhibits Collagen-Induced Arthritis and VEGF-Stimulated Productions of TNF-α and IL-6 by Human Monocytes 1
暂无分享,去创建一个
Chi-Bom Chae | Wan-Uk Kim | Hae-Rim Kim | Wan-Uk Kim | C. Cho | Chul-Soo Cho | Seung-Ah Yoo | Dong-Goo Bae | Jae-Woong Ryoo | Hae-Rim Kim | Gyeong-Sin Park | C. Chae | S. Yoo | D. Bae | Gyeongsin Park | J. Ryoo | Seung-Ah Yoo | Dong-Goo Bae
[1] T. Ishiwata,et al. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis. , 1995, The Journal of rheumatology.
[2] G. J. Swaminathan,et al. The Crystal Structure of Human Placenta Growth Factor-1 (PlGF-1), an Angiogenic Protein, at 2.0 Å Resolution* , 2001, The Journal of Biological Chemistry.
[3] A. Ullrich,et al. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant , 1994, Nature.
[4] T. Tarrade,et al. Pharmacokinetic, metabolic, and antidiarrheal properties of (d and l) heptapeptides of sorbin in rodent , 1995, Peptides.
[5] H. Fujiwara,et al. Type II collagen-induced murine arthritis. I. Induction and perpetuation of arthritis require synergy between humoral and cell-mediated immunity. , 1988, Journal of immunology.
[6] R. E. Click,et al. Immune responses in vitro: V. Role of mercaptoethanol in the mixed-leukocyte reaction , 1972 .
[7] R. Busse,et al. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. , 1999, Diabetes.
[8] L. Pirilä,et al. H-ras oncogene point mutations in arthritic synovium. , 1997, Arthritis and rheumatism.
[9] D. Green,et al. Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[10] A. Luttun,et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.
[11] Vittorio,et al. Tumour necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis. , 1990, Annals of the rheumatic diseases.
[12] A. Billiau,et al. Anti‐IL‐12 antibody prevents the development and progression of collagen‐induced arthritis in IFN‐γ receptor‐deficient mice , 1998, European journal of immunology.
[13] H. Matsuno,et al. CD4+ T cells from collagen‐induced arthritic mice are essential to transfer arthritis into severe combined immunodeficient mice , 1994, Clinical and experimental immunology.
[14] B. Beutler,et al. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts , 1985, The Journal of experimental medicine.
[15] F. Brown,et al. A retro-inverso peptide corresponding to the GH loop of foot-and-mouth disease virus elicits high levels of long-lasting protective neutralizing antibodies. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] Sung-Hwan Park,et al. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[17] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.
[18] Jong-sang Park,et al. Suppression of collagen-induced arthritis by single administration of poly(lactic-co-glycolic acid) nanoparticles entrapping type II collagen: a novel treatment strategy for induction of oral tolerance. , 2002, Arthritis and rheumatism.
[19] R. Natarajan,et al. Mechanism of cigarette smoke condensate induced adhesion of human monocytes to cultured endothelial cells , 1994, Journal of cellular physiology.
[20] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[21] Shin-Seok Lee,et al. CD40 Engagement on Synovial Fibroblast Up-Regulates Production of Vascular Endothelial Growth Factor1 , 2000, The Journal of Immunology.
[22] G. Neufeld,et al. Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] M. Feldmann,et al. TNF alpha--a pivotal role in rheumatoid arthritis? , 1992, British journal of rheumatology.
[24] M. Feldmann,et al. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. , 1998, Arthritis and rheumatism.
[25] M. Morimatsu,et al. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. , 1992, Arthritis and rheumatism.
[26] A. Koch,et al. Angiogenesis: Implications for rheumatoid arthritis , 1998 .
[27] A. Luttun,et al. Placental growth factor and its receptor, vascular endothelial growth factor receptor‐1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders , 2003, Journal of thrombosis and haemostasis : JTH.
[28] M. Klagsbrun,et al. Regulators of angiogenesis. , 1991, Annual review of physiology.
[29] E. Tindall,et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. , 1997, The New England journal of medicine.
[30] G. Firestein,et al. Starving the synovium: angiogenesis and inflammation in rheumatoid arthritis. , 1999, The Journal of clinical investigation.
[31] N. Olsen,et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue , 1994, The Journal of experimental medicine.
[32] N. Perelman,et al. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. , 2003, Blood.
[33] Y. Gho,et al. Arginine-rich Anti-vascular Endothelial Growth Factor Peptides Inhibit Tumor Growth and Metastasis by Blocking Angiogenesis* , 2000, The Journal of Biological Chemistry.
[34] P. Guerne,et al. Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. , 1989, The Journal of clinical investigation.
[35] R. Maciewicz,et al. Treatment with Soluble VEGF Receptor Reduces Disease Severity in Murine Collagen-Induced Arthritis , 2000, Laboratory Investigation.
[36] A. Kang,et al. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis , 1982, The Journal of experimental medicine.
[37] Seung-Hoon Lee,et al. Vascular Endothelial Growth Factor Modulates Neutrophil Transendothelial Migration via Up-regulation of Interleukin-8 in Human Brain Microvascular Endothelial Cells* , 2002, The Journal of Biological Chemistry.
[38] G. Firestein. Somatic mutation in the tumore suppressor gene in erosive rheumatoid arthritis synovium , 1997 .
[39] B. Bresnihan,et al. Morphometric analysis of blood vessels in synovial membranes obtained from clinically affected and unaffected knee joints of patients with rheumatoid arthritis. , 1991, Annals of the rheumatic diseases.
[40] Sung-Hwan Park,et al. Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor a production by rheumatoid synoviocytes. , 2002, Arthritis and rheumatism.
[41] J. Vilček,et al. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. , 1989, Laboratory investigation; a journal of technical methods and pathology.
[42] H. Shimano,et al. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. , 2001, Biochemical and biophysical research communications.
[43] P. Bohlen,et al. Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis 1 , 2003, The Journal of Immunology.
[44] R. E. Click,et al. Immune responses in vitro. I. Culture conditions for antibody synthesis. , 1972, Cellular immunology.
[45] S. S. Lee,et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. , 2001, Clinical and experimental rheumatology.